LT - PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.
EN - PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 9/16 |
|
|
|
A61K 9/20 |
|
|
|
A61K 31/496 |
|
European patent
| (11) |
Number of the document |
2588086 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
11734043.0 |
|
Date of filing the European patent application |
2011-06-29 |
| (97) |
Date of publication of the European application |
2013-05-08 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-09-12
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2011/060949 |
|
Date |
2011-06-29 |
PCT application publication
| (87) |
Number |
WO 2012/001074 |
|
Date |
2012-01-05 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
10168028 |
2010-06-30
|
EP |
Inventors
| (72) |
THAKUR, Jeewan, CH
QIU, Zhihui, CN
|
Grantee
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Title
| (54) |
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE. |
| |
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE. |
